Literature DB >> 18414893

Anasarca: not a nephrotic syndrome but dermatomyositis.

Magdy Zedan1, Moustafa El-Ayouty, Hesham Abdel-Hady, Basma Shouman, Mohamed El-Assmy, Ashraf Fouda.   

Abstract

Juvenile dermatomyositis (JDM) is a rare autoimmune disease characterized by inflammation of the muscle, connective tissue, skin, gastrointestinal tract, and small nerves. Periorbital and facial edema may also be associated. Although localized edema is a common feature of JDM, generalized edema has rarely been reported. Here, we report a 3.5-year-old boy with JDM presenting with generalized edema. The diagnostic criteria of JDM rely on typical clinical manifestations that include: severe symmetric weakness of the proximal musculature, characteristic cutaneous changes, elevated serum skeletal muscle enzymes, and myopathic electromyographic pattern. Our patient initially received methylprednisolone and intravenous immunoglobulin (IVIG) without significant improvement, so he was given azathioprine and a prolonged course of oral prednisolone. We conclude that JDM should be suspected in patients presenting with anasarca in the absence of laboratory parameters of other causes of generalized edema and an appearance of heliotrope rash with muscle weakness. Also, we suggest that muscle magnetic resonance imaging (MRI) should be considered among the diagnostic tools of JDM.

Entities:  

Mesh:

Year:  2008        PMID: 18414893     DOI: 10.1007/s00431-008-0716-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

Review 1.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  Juvenile dermatomyositis associated with hereditary angioneurotic oedema.

Authors:  R Narasimhan; R Lakshman; R S Amos; L H P Williams; W Egner; A Finn
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

3.  DERMATOMYOSITIS AND FOCAL SCLERODERMA.

Authors:  C D COOK; F S ROSEN; B Q BANKER
Journal:  Pediatr Clin North Am       Date:  1963-11       Impact factor: 3.278

4.  Dermatomyositis; report of 26 cases in children with a discussion of endocrine therapy in 13.

Authors:  R J WEDGWOOD; C D COOK; J COHEN
Journal:  Pediatrics       Date:  1953-10       Impact factor: 7.124

5.  Juvenile dermatomyositis presenting with anasarca.

Authors:  Sumit Mehndiratta; Prabhabati Banerjee
Journal:  Indian Pediatr       Date:  2004-07       Impact factor: 1.411

6.  Dermatomyositis in early childhood.

Authors:  P SELANDER
Journal:  Acta Med Scand Suppl       Date:  1950

Review 7.  Juvenile dermatomyositis.

Authors:  A L Norins
Journal:  Med Clin North Am       Date:  1989-09       Impact factor: 5.456

8.  Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activity.

Authors:  J P Mitchell; G J Dennis; L G Rider
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

9.  A rare complication of generalized edema in juvenile dermatomyositis: a report of one case.

Authors:  Hamza Karabiber; Mehmet Aslan; Alpay Alkan; Cengiz Yakinci
Journal:  Brain Dev       Date:  2004-06       Impact factor: 1.961

  9 in total
  4 in total

1.  Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.

Authors:  Anna Rogers; Lorinda Chung; Shufeng Li; Livia Casciola-Rosen; David F Fiorentino
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-02       Impact factor: 4.794

2.  Anasarca as the initial presentation of juvenile polymyositis: an uncommon occurrence.

Authors:  Dhrubajyoti Sharma; Surjit Singh; Deepti Suri; Amit Rawat; Upender Shava; Kushaljit S Sodhi
Journal:  Rheumatol Int       Date:  2011-07-31       Impact factor: 2.631

3.  Nephrotic syndrome and juvenile dermatomyositis.

Authors:  Azar Nickavar; Mitra Mehr Azma
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

4.  Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.

Authors:  Emily E Schildt; Deirdre De Ranieri
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-13       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.